Pharmicell Co.,Ltd.
Biopharma firm in stem cell therapies, biochemicals, cell banking, and stem cell cosmetics.
005690 | KO
Overview
Corporate Details
- ISIN(s):
- KR7005690003
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 강남구 언주로 874 (신사동, 쌍봉빌딩 7층), 강남구
- Website:
- https://www.pharmicell.com/eng/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Pharmicell Co., Ltd. is a biopharmaceutical company specializing in stem cell technology. The company is a pioneer in the field, having developed and commercialized Hearticellgram®-AMI, the world's first approved stem cell therapy for acute myocardial infarction. Its business is diversified across four main segments: stem cell therapeutics, including ongoing research for conditions like liver disease; a biochemical division that conducts oligonucleotide synthesis and produces nucleosides, mPEGs, and pharmaceutical intermediates; a stem cell banking business for adult and cord blood ('Twelve' brand); and a line of cosmetics derived from stem cell culture media ('By Pharmicell lab' brand).
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-21 00:00 |
Regulatory News Service
단일판매ㆍ공급계약체결
|
Korean | 7.6 KB | ||
| 2025-08-13 00:00 |
Annual Report
[기재정정]사업보고서 (2024.12)
|
Korean | 1.0 MB | ||
| 2025-08-13 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 779.0 KB | ||
| 2025-07-15 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 110.2 KB | ||
| 2025-07-08 00:00 |
Report Publication Announcement
기업설명회(IR)개최(안내공시)
|
Korean | 6.1 KB | ||
| 2025-05-08 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 785.5 KB | ||
| 2025-04-30 00:00 |
Regulatory News Service
단일판매ㆍ공급계약체결
|
Korean | 7.6 KB | ||
| 2025-04-30 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.2 KB | ||
| 2025-04-30 00:00 |
Major Shareholding Notification
최대주주등소유주식변동신고서
|
Korean | 32.6 KB | ||
| 2025-04-29 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 111.8 KB | ||
| 2025-04-22 00:00 |
Regulatory News Service
단일판매ㆍ공급계약체결
|
Korean | 7.6 KB | ||
| 2025-04-01 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 118.0 KB | ||
| 2025-04-01 00:00 |
Major Shareholding Notification
최대주주등소유주식변동신고서
|
Korean | 32.6 KB | ||
| 2025-03-26 00:00 |
Post-Annual General Meeting Information
정기주주총회결과
|
Korean | 28.9 KB | ||
| 2025-03-26 00:00 |
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | 11.0 KB |
Automate Your Workflow. Get a real-time feed of all Pharmicell Co.,Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pharmicell Co.,Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pharmicell Co.,Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
